Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients.
about
Genetics of cardiovascular and renal complications in diabetesDiabetic nephropathy research in China: Data analysis and review from the National Natural Science Foundation of China.Identified single-nucleotide polymorphisms and haplotypes at 16q22.1 increase diabetic nephropathy risk in Han Chinese populationAssociation of the variants in the PPARG gene and serum lipid levels: a meta-analysis of 74 studies.Relationship between PPARγ Pro12Ala gene polymorphism and type 2 diabetic nephropathy risk in Asian population: results from a meta-analysis.The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes.Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studiesMeta-analysis of association between the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ2 gene and diabetic retinopathy in Caucasians and AsiansGenetic and environmental factors associated with type 2 diabetes and diabetic vascular complications.The association of genetic variants of type 2 diabetes with kidney functionThe association between the PPARγ2 Pro12Ala polymorphism and nephropathy susceptibility in type 2 diabetes: a meta-analysis based on 9,176 subjects.The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis.Smoking as a risk factor for diabetic nephropathy: a meta-analysis.The angiotensin-I converting enzyme gene I/D variation contributes to end-stage renal disease risk in Chinese patients with type 2 diabetes receiving hemodialysis.Peroxisome proliferator-activated receptor γ Pro12Ala polymorphism decrease the risk of diabetic nephropathy in type 2 diabetes: a meta analysis.Comment on: Zhang et al. Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies. Diabetes Care 2012;35:1388-1393.Arg913Gln of SLC12A3 gene promotes development and progression of end-stage renal disease in Chinese type 2 diabetes mellitus.Association analysis of PPARγ (p.Pro12Ala) polymorphism with type 2 diabetic retinopathy in patients from north India.PPAR 2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studies
P2860
Q26752749-70167E8D-0D39-4123-9DDD-5C45B0E32528Q30883079-32AC5FE6-51F6-4B16-AB69-D6169FD16C3FQ34463264-72FF035F-57AC-42E7-81A1-2936E89D9F3BQ34885498-1FD5A591-4247-47BF-ADEF-22DE474FC11BQ35058771-F65FABEE-A19F-4330-893E-783B0412153FQ35174597-E9DFB829-7E03-40A9-A4C8-EB5C6A36948FQ35976372-A73CA8D2-ED99-4B54-B942-975D745E7B85Q36239731-2A477FD5-CD84-4D9F-962A-8B8002B43CC8Q36250613-A6E59B84-E71C-4554-8830-CC7EB783C11DQ36877238-96C301DC-9DD6-400B-8876-0E824C0B6057Q38121659-E0582690-C61E-431B-ACD5-941C90415C55Q38254887-89E58F67-B369-49D6-B1F7-531B241CEF0FQ38718018-25DBEA16-78BF-4120-B335-7C8619499410Q40579516-0885BE17-D101-4B01-A02F-CB1651423120Q42364753-8A91C14A-70D6-4120-9B8B-0DDF3669E76FQ42419517-15860AD4-7812-4441-89AA-BB09E5642736Q44361832-8CEF0308-1B27-48F0-91FD-5A6E6752C81DQ51635073-1B0EEDC2-7938-4444-9AC9-133AE2EEECE0Q57701985-89F4FF22-387A-4324-A9FD-F42F4EA8D096
P2860
Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients.
description
2009 nî lūn-bûn
@nan
2009 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.
@ast
Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.
@en
Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.
@nl
type
label
Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.
@ast
Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.
@en
Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.
@nl
prefLabel
Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.
@ast
Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.
@en
Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.
@nl
P2093
P2860
P356
P1433
P1476
Pro12Ala polymorphism in the P ...... nese type 2 diabetic patients.
@en
P2093
Jiamei Jiang
Niansong Wang
Taishan Zheng
Weijing Zhao
Yanyan Song
P2860
P304
P356
10.2337/DC09-1258
P407
P577
2009-10-16T00:00:00Z